Cargando…
Generation of HepG2 Cells with High Expression of Multiple Drug-Metabolizing Enzymes for Drug Discovery Research Using a PITCh System
HepG2 cells are an inexpensive hepatocyte model that can be used for repeated experiments, but HepG2 cells do not express major cytochrome P450s (CYPs) and UDP glucuronosyltransferase family 1 member A1 (UGT1A1). In this study, we established CYP3A4–POR–UGT1A1–CYP1A2–CYP2C19–CYP2C9–CYP2D6 (CYPs–UGT1...
Autores principales: | Negoro, Ryosuke, Tasaka, Mitsuki, Deguchi, Sayaka, Takayama, Kazuo, Fujita, Takuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140068/ https://www.ncbi.nlm.nih.gov/pubmed/35626714 http://dx.doi.org/10.3390/cells11101677 |
Ejemplares similares
-
Establishment of SLC15A1/PEPT1-Knockout Human-Induced Pluripotent Stem Cell Line for Intestinal Drug Absorption Studies
por: Kawai, Kanae, et al.
Publicado: (2019) -
The idiosyncratic drug-induced gene expression changes in HepG2 cells
por: Jiang, J., et al.
Publicado: (2017) -
Hypoxia induces the expression of TET enzymes in HepG2 cells
por: Lin, Guofu, et al.
Publicado: (2017) -
Development of multi-drug resistance to anticancer drugs in HepG2 cells due to MRP2 upregulation on exposure to menthol
por: Nagai, Katsuhito, et al.
Publicado: (2023) -
The rediscovery of HepG2 cells for prediction of drug induced liver injury (DILI)
por: Ghallab, Ahmed
Publicado: (2014)